Making Medicines is a concise, chronological discussion of the history of therapeutics and pharmacy from the Egyptians through to the present day. It focuses on the discovery and uses of medicines to treat illness through the ages, and the evolving role of the pharmacist. Each chapter is contributed by an expert in the period or field, and illustrates how wider social, political and economic developments have influenced drug development and shaped pharmacy practice.The book has two colour-plate sections illustrating how pharmacy has developed over the centuries. Numerous photographs are also included in the text.Written by an expert in the field, this book will appeal to pharmacists and pharmacy students, as well as to other healthcare practitioners and medical historians.

This book is open access under a CC-BY license. The importance of the pharmaceutical industry in Sub-Saharan Africa, its claim to policy priority, is rooted in the vast unmet health needs of the sub-continent. Making Medicines in Africa is a collective endeavour, by a group of contributors with a strong African and more broadly Southern presence, to find ways to link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care in Africa. The authors aim to shift the emphasis in international debate and initiatives towards sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle its populations' needs and demands. Research for this book has been selected as one of the 20 best examples of the impact of UK research on development. See http://www.ukcds.org.uk/the-global-impact-of-uk-research for further details.

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Medical care in nineteenth-century China was spectacularly pluralistic: herbalists, shamans, bone-setters, midwives, priests, and a few medical missionaries from the West all competed for patients. In the century that followed, pressure to reform traditional medicine in China came not only from this small clutch of Westerners, but from within the country itself, as governments set on modernization aligned themselves against the traditions of the past, and individuals saw in the Western system the potential for new wealth and power. This book examines the dichotomy between “Western” and “Chinese” medicine, showing how it has been greatly exaggerated. As missionaries went to lengths to make their medicine more acceptable to Chinese patients, modernizers of Chinese medicine worked to become more “scientific” by eradicating superstition and creating modern institutions. Andrews challenges the supposed superiority of Western medicine in China while showing how “traditional” Chinese medicine was deliberately created in the image of a modern scientific practice.

Conceptions of medicine and medical practice among the Kedjom peoples in Cameroon embrace more than western biomedical understandings of medicine. For these peoples, medicine implies substances, knowledge, practices and institutions bound up with protection and intervention against misfortune and the active promotion of well-being. Nor are medical concerns primarily about the individual. Medicine in the precolonial era was a matter for groups. In short, medicine was preeminently public. Perhaps the major transformation since the colonial period and extending into the postcolonial, has been the increasing commercialization of "traditional" medicine as African healers shift their practices away from group concerns to a focus more concerned with treating the individual. Written in a lucid style, full of vibrant anecdotes, Maynard's book will appeal not only to medical anthropologists and development workers, but also to anyone interested in nonwestern medicine and practices.

A study of the Speziale al Giglio apothecary shop in fifteenth-century Florence, Italy.

How do scientists design the medicine we use to improve our lives? It turns out that many are happy accidents or overlooked mixtures of carbon and hydrogen that go on to not only improve the lives of people the world over, but become million- and billion-dollar makers for pharmaceutical companies. In Making Medicine: Surprising Stories from the History of Drug Discovery, author Keith Veroneseexamines fifteen different molecules and their unlikely discovery –or in many cases, their second discovery –en route to becoming invaluable medications. From the famous story of Alexander Fleming’s discovery of penicillin, to lesser-known stories surrounding drugs like quinine (derived from the bark of the cinchona tree and responsible for saving the lives of millions in the fight against malaria), Veronese reveals the “how” and the “who” behind the pharmaceutical breakthroughs that continue to impact our world. With subjects including cancer-fighting therapies and over-the-counter pain relievers; hair regrowth creams and antidepressants; readers will no doubt have a personal connection to at least one molecule in this book. Like all discoveries made by mankind, the stories behind these breakthroughs and their introduction to the world are often messy, sometimes controversial, and always human. Take digoxin, which correctly prescribed can help heart efficiency, but in higher doses can prove fatal –a fact known all too well by Charles Cullen, a nurse who used digoxin to kill over forty patients. Making Medicine also details how modern pharmaceutical discovery works, including the monumental challenge and accomplishment of creating a COVID-19 vaccine. This fascinating book highlights the serendipitous nature of the discovery of these miracle molecules, along with how they do (or don't) interact with the human body to produce the desired result.

This book offers a multidisciplinary look at the much-debated concept of “personalized medicine”. By combining a humanistic and a scientific approach, the book builds up a multidimensional way to understand the limits and potentialities of a personalized approach in medicine and healthcare. The book reflects on personalized medicine and complex diseases, the relationship between personalized medicine and the new bio-technologies, personalized medicine and personalized nutrition, and on some ethical, political, economic, and social implications of personalized medicine. This volume is of interest to researchers from several disciplines including philosophy, bio-medicine, and the social sciences. Chapter 16, “The Impact of Fantasy” is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.

A biography of the English physician and scientist and a history of the advancement of science in the Victorian era. In Victorian Britain, scientific medicine encompassed an array of activities, from laboratory research and the use of medical technologies through the implementation of sanitary measures that drained canals and prevented the adulteration of milk and bread. Although most practitioners supported scientific medicine, controversies arose over where decisions should be made, in the laboratory or in the clinic, and by whom—medical practitioners or research scientists. In this study, Terrie Romano uses the life and eclectic career of Sir John Burdon Sanderson (1829-1905) to explore the Victorian campaign to make medicine scientific. Sanderson, a prototypical Victorian, began his professional work as a medical practitioner and Medical Officer of Health in London, then became a pathologist and physiologist and eventually the Regius Professor of Medicine at Oxford. His career illustrates the widespread support during this era for a medicine based on science. In Making Medicine Scientific, Romano argues this support was fueled by the optimism characteristic of the Victorian age, when the application of scientific methods to a range of social problems was expected to achieve progress. Dirt and disease as well as the material culture of experimentation —from frogs to photographs—represent the tangible context in which Sanderson lived and worked. Romano’s detailed portrayal reveals a fascinating figure who embodied the untidy nature of the Victorian age’s shift from an intellectual system rooted in religion to one based on science. “A useful entry in the canon of science and public health . . . an antidote to the hubris of recent claims of accomplishment.” —Choice

The more we know about medicine, the more we realize that many health questions have no one true answer. Realizing this, and thinking carefully about how medicine asks patients to treat their conditions, leads us to some questions. How reliable are the guidelines that might form the basis of doctors’ advice? Is it wrong, after all, to base an approach to medicine on patients’ preferences? And, given that there is often a distance between the treatment a doctor advises and what a patient would like to do, how do we bridge the gap—especially in a health culture of inequality, technical proficiency, and increasing costs? In practical, engaging, narrative-driven chapters about common health conditions that millions of Americans are familiar with—depression and high blood pressure, arthritis and diabetes—Dr. Zackary Berger of Johns Hopkins demystifies the often bewildering disconnect between patients and doctors and asks us all to think more clearly about how best to protect and cure the human body.